Founded
16 Jul 2003
Address
Abingworth Bioventures IV LP
38 Jermyn Street
London
SW1Y 6DN
United Kingdom
Website
VCID: 28362
Profile
Corporate information
Official name
Abingworth Bioventures IV Limited Partnership
Registration country
Official name
Abingworth Bioventures IV Limited Partnership
Registration country
Investment activity status
Not investing
Company type
Venture capital fundFund terms
Funding
Funding rounds
Fund Closing USD 350,000,000
USD 350,000,000 (31 Dec 2003)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
ATP Private Equity Partners I K/S | Denmark | ||
|
Pennsylvania State Employees' Retirement System | United States |
Cap Table
Current and past shareholders
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Zogenix Inc A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. |
United States | 1 Sep 2009 31 Dec 2007 |
Series B Initial investment. Round participant. Active |
|
|
Akubio Ltd Provider of acoustic detection systems for real time analysis of biomolecular behavior |
United States | 31 Dec 2007 | N/A Active |
|
|
|
Prosensa |
Netherlands | 31 Dec 2006 | N/A Active |
|
|
|
Supernus Pharmaceuticals Inc |
United States | 31 Dec 2006 | N/A Active |
|
|
|
Intelligent Medical Implants |
Germany | 31 Dec 2006 | N/A Active |
|
|
|
Magellan |
United States | 31 Dec 2006 | N/A Active |
|
|
|
Broncus Technologies Inc Developer of interventional bronchoscopy devices for the treatment of chronic lung diseases. |
United States | 31 Dec 2006 | N/A Active |
|
|
|
Fovea Pharmaceuticals |
France | 31 Dec 2005 | N/A Active |
|
|
|
Gynesonics |
United States | 31 Dec 2005 | N/A Active |
|
|
|
Synosia Therapeutics Develops innovative treatments for disorders of the central nervous system |
United States | 31 Dec 2005 | N/A Active |
|
|
|
Syntaxin Ltd |
United Kingdom | 31 Dec 2005 | N/A Active |
|
|
|
Alexza Pharmaceuticals Inc |
United States | 31 Dec 2005 | N/A Active |
|
|
|
Dynogen Pharmaceuticals Inc Drug company focused on gastrointestinal and genitourinary disorders. |
United States | 31 Dec 2004 | N/A Active |
|
|
|
Powder Med |
United Kingdom | 31 Dec 2004 | N/A Active |
|
|
|
Ablynx NV |
Belgium | 31 Dec 2004 | Other Active |
|
|
|
Novexel |
France | 31 Dec 2004 | N/A Active |
|
|
|
Portola Pharmaceuticals Inc |
United States | 31 Dec 2003 | N/A Active |
|
|
|
Healthcare Brands Intl Ltd Committed to translating innovative science into meaningful consumer brands. Sold subsidiary, Antula Healthcare, for SEK 1.8bn in April 2011. |
United Kingdom | N/A |